HK Stock MarketDetailed Quotes

09868 XPENG-W

Watchlist

50.000
+1.250+2.56%

Market Closed Dec 4 16:08 CST

94.96BMarket Cap-14744P/E (TTM)

XPENG-W Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Turnover

40.48%24.76B

61.16%14.66B

62.35%6.55B

14.23%30.68B

-18.83%17.63B

-38.92%9.1B

-45.90%4.03B

27.95%26.86B

74.67%21.71B

121.85%14.89B

Operating income

40.48%24.76B

61.16%14.66B

62.35%6.55B

14.23%30.68B

-18.83%17.63B

-38.92%9.1B

-45.90%4.03B

27.95%26.86B

74.67%21.71B

121.85%14.89B

Cost of sales

-18.11%-21.24B

-37.43%-12.68B

-43.82%-5.7B

-27.17%-30.22B

5.70%-17.98B

29.95%-9.23B

39.39%-3.97B

-29.41%-23.77B

-76.05%-19.07B

-121.97%-13.17B

Operating expenses

-18.11%-21.24B

-37.43%-12.68B

-43.82%-5.7B

-27.17%-30.22B

5.70%-17.98B

29.95%-9.23B

39.39%-3.97B

-29.41%-23.77B

-76.05%-19.07B

-121.97%-13.17B

Gross profit

1,082.65%3.52B

1,618.53%1.98B

1,158.73%843.75M

-85.39%451.16M

-113.56%-358.32M

-107.58%-130.36M

-92.64%67.03M

17.76%3.09B

65.29%2.64B

120.97%1.72B

Selling expenses

0.59%-4.6B

-1.09%-2.96B

-0.13%-1.39B

1.93%-6.56B

6.28%-4.62B

11.37%-2.93B

15.53%-1.39B

-26.06%-6.69B

-49.92%-4.93B

-88.75%-3.31B

Research and development expenses

-12.13%-4.45B

-5.79%-2.82B

-4.21%-1.35B

-1.18%-5.28B

0.40%-3.97B

-7.11%-2.66B

-6.11%-1.3B

-26.75%-5.21B

-49.64%-3.98B

-77.76%-2.49B

Revaluation surplus

--29.61M

--191.79M

--175.13M

--29.34M

----

-Changes in the fair value of derivative financial instruments

--29.61M

--191.79M

--175.13M

--29.34M

----

Special items of operating profit

247.00%392.79M

635.10%352.88M

146.27%74.04M

326.49%465.59M

31.91%113.2M

-21.29%48.01M

-5.03%30.07M

-49.86%109.17M

-57.92%85.81M

146.84%60.99M

Operating profit

42.26%-5.1B

42.65%-3.26B

36.34%-1.65B

-25.09%-10.89B

-42.80%-8.84B

-41.49%-5.68B

-34.62%-2.59B

-32.31%-8.71B

-49.12%-6.19B

-70.90%-4.01B

Financing income

17.00%1.07B

25.18%755.33M

33.00%398.65M

19.02%1.26B

16.80%917.38M

21.78%603.38M

31.50%299.74M

42.49%1.06B

63.96%785.4M

73.76%495.45M

Financing cost

-27.91%-249.98M

-28.41%-166.52M

-35.83%-85.12M

-103.24%-268.67M

-140.95%-195.44M

-207.69%-129.67M

-215.96%-62.67M

-138.89%-132.19M

-95.48%-81.11M

-67.59%-42.15M

Special items of earning before tax

78.58%-202.55M

-260.63%-39.79M

-271.13%-28.28M

62.99%-495.77M

24.85%-945.59M

103.00%24.77M

17.93%16.53M

-227.01%-1.34B

-1,021.27%-1.26B

-879.53%-826.18M

Earning before tax

50.54%-4.48B

47.73%-2.71B

41.64%-1.36B

-13.99%-10.39B

-34.38%-9.06B

-18.09%-5.18B

-37.30%-2.33B

-88.51%-9.12B

-88.56%-6.74B

-121.29%-4.38B

Tax

270.62%25.69M

327.58%32.71M

82.78%-1.06M

-48.84%-36.81M

57.20%-15.06M

-1.52%-14.37M

-154.00%-6.16M

4.84%-24.73M

-11,509.24%-35.18M

---14.16M

After-tax profit from continuing operations

50.90%-4.46B

48.51%-2.67B

41.75%-1.36B

-14.08%-10.43B

-33.90%-9.08B

-18.03%-5.19B

-37.46%-2.34B

-88.01%-9.14B

-89.53%-6.78B

-122.01%-4.4B

Special items of earning after tax

-109.96%-4.67M

-58.42%20.73M

-724.77%-6.1M

1,229.61%54.74M

9,284.54%46.93M

1,582.31%49.85M

--977K

--4.12M

---511K

---3.36M

Earning after tax

50.60%-4.46B

48.41%-2.65B

41.47%-1.37B

-13.53%-10.38B

-33.20%-9.03B

-16.81%-5.14B

-37.41%-2.34B

-87.92%-9.14B

-89.54%-6.78B

-122.18%-4.4B

Profit attributable to shareholders

50.60%-4.46B

48.41%-2.65B

41.47%-1.37B

-13.53%-10.38B

-33.20%-9.03B

-16.81%-5.14B

-37.41%-2.34B

-87.92%-9.14B

-89.54%-6.78B

-122.18%-4.4B

Basic earnings per share

54.88%-2.36

52.68%-1.41

46.32%-0.73

-11.61%-5.96

-32.07%-5.23

-15.50%-2.98

-36.00%-1.36

-80.41%-5.34

-80.82%-3.96

-106.40%-2.58

Diluted earnings per share

54.88%-2.36

52.68%-1.41

46.32%-0.73

-11.61%-5.96

-32.07%-5.23

-15.50%-2.98

-36.00%-1.36

-80.41%-5.34

-80.82%-3.96

-106.40%-2.58

Currency Unit

CNY

Accounting Standards

UAS

Audit Opinions

Unqualified Opinion

Auditor

PricewaterhouseCoopers

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Turnover	40.48%24.76B	61.16%14.66B	62.35%6.55B	14.23%30.68B	-18.83%17.63B	-38.92%9.1B	-45.90%4.03B	27.95%26.86B	74.67%21.71B	121.85%14.89B
Operating income	40.48%24.76B	61.16%14.66B	62.35%6.55B	14.23%30.68B	-18.83%17.63B	-38.92%9.1B	-45.90%4.03B	27.95%26.86B	74.67%21.71B	121.85%14.89B
Cost of sales	-18.11%-21.24B	-37.43%-12.68B	-43.82%-5.7B	-27.17%-30.22B	5.70%-17.98B	29.95%-9.23B	39.39%-3.97B	-29.41%-23.77B	-76.05%-19.07B	-121.97%-13.17B
Operating expenses	-18.11%-21.24B	-37.43%-12.68B	-43.82%-5.7B	-27.17%-30.22B	5.70%-17.98B	29.95%-9.23B	39.39%-3.97B	-29.41%-23.77B	-76.05%-19.07B	-121.97%-13.17B
Gross profit	1,082.65%3.52B	1,618.53%1.98B	1,158.73%843.75M	-85.39%451.16M	-113.56%-358.32M	-107.58%-130.36M	-92.64%67.03M	17.76%3.09B	65.29%2.64B	120.97%1.72B
Selling expenses	0.59%-4.6B	-1.09%-2.96B	-0.13%-1.39B	1.93%-6.56B	6.28%-4.62B	11.37%-2.93B	15.53%-1.39B	-26.06%-6.69B	-49.92%-4.93B	-88.75%-3.31B
Research and development expenses	-12.13%-4.45B	-5.79%-2.82B	-4.21%-1.35B	-1.18%-5.28B	0.40%-3.97B	-7.11%-2.66B	-6.11%-1.3B	-26.75%-5.21B	-49.64%-3.98B	-77.76%-2.49B
Revaluation surplus	--29.61M	--191.79M	--175.13M	--29.34M	----	----	----	----	----	----
-Changes in the fair value of derivative financial instruments	--29.61M	--191.79M	--175.13M	--29.34M	----	----	----	----	----	----
Special items of operating profit	247.00%392.79M	635.10%352.88M	146.27%74.04M	326.49%465.59M	31.91%113.2M	-21.29%48.01M	-5.03%30.07M	-49.86%109.17M	-57.92%85.81M	146.84%60.99M
Operating profit	42.26%-5.1B	42.65%-3.26B	36.34%-1.65B	-25.09%-10.89B	-42.80%-8.84B	-41.49%-5.68B	-34.62%-2.59B	-32.31%-8.71B	-49.12%-6.19B	-70.90%-4.01B
Financing income	17.00%1.07B	25.18%755.33M	33.00%398.65M	19.02%1.26B	16.80%917.38M	21.78%603.38M	31.50%299.74M	42.49%1.06B	63.96%785.4M	73.76%495.45M
Financing cost	-27.91%-249.98M	-28.41%-166.52M	-35.83%-85.12M	-103.24%-268.67M	-140.95%-195.44M	-207.69%-129.67M	-215.96%-62.67M	-138.89%-132.19M	-95.48%-81.11M	-67.59%-42.15M
Special items of earning before tax	78.58%-202.55M	-260.63%-39.79M	-271.13%-28.28M	62.99%-495.77M	24.85%-945.59M	103.00%24.77M	17.93%16.53M	-227.01%-1.34B	-1,021.27%-1.26B	-879.53%-826.18M
Earning before tax	50.54%-4.48B	47.73%-2.71B	41.64%-1.36B	-13.99%-10.39B	-34.38%-9.06B	-18.09%-5.18B	-37.30%-2.33B	-88.51%-9.12B	-88.56%-6.74B	-121.29%-4.38B
Tax	270.62%25.69M	327.58%32.71M	82.78%-1.06M	-48.84%-36.81M	57.20%-15.06M	-1.52%-14.37M	-154.00%-6.16M	4.84%-24.73M	-11,509.24%-35.18M	---14.16M
After-tax profit from continuing operations	50.90%-4.46B	48.51%-2.67B	41.75%-1.36B	-14.08%-10.43B	-33.90%-9.08B	-18.03%-5.19B	-37.46%-2.34B	-88.01%-9.14B	-89.53%-6.78B	-122.01%-4.4B
Special items of earning after tax	-109.96%-4.67M	-58.42%20.73M	-724.77%-6.1M	1,229.61%54.74M	9,284.54%46.93M	1,582.31%49.85M	--977K	--4.12M	---511K	---3.36M
Earning after tax	50.60%-4.46B	48.41%-2.65B	41.47%-1.37B	-13.53%-10.38B	-33.20%-9.03B	-16.81%-5.14B	-37.41%-2.34B	-87.92%-9.14B	-89.54%-6.78B	-122.18%-4.4B
Profit attributable to shareholders	50.60%-4.46B	48.41%-2.65B	41.47%-1.37B	-13.53%-10.38B	-33.20%-9.03B	-16.81%-5.14B	-37.41%-2.34B	-87.92%-9.14B	-89.54%-6.78B	-122.18%-4.4B
Basic earnings per share	54.88%-2.36	52.68%-1.41	46.32%-0.73	-11.61%-5.96	-32.07%-5.23	-15.50%-2.98	-36.00%-1.36	-80.41%-5.34	-80.82%-3.96	-106.40%-2.58
Diluted earnings per share	54.88%-2.36	52.68%-1.41	46.32%-0.73	-11.61%-5.96	-32.07%-5.23	-15.50%-2.98	-36.00%-1.36	-80.41%-5.34	-80.82%-3.96	-106.40%-2.58
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	UAS	UAS	UAS	UAS	UAS	UAS	UAS	UAS	UAS	UAS
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--
Auditor	--	--	--	PricewaterhouseCoopers	--	--	--	PricewaterhouseCoopers	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.